Detalles de la búsqueda
1.
Significance of the autoantibody assay in predicting the development of immune-related adverse events in patients receiving atezolizumab plus bevacizumab combination therapy for unresectable hepatocellular carcinoma.
Hepatol Res
; 54(2): 162-173, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37740643
2.
RECAM-J 2023-Validation and development of the Japanese version of RECAM for the diagnosis of drug-induced liver injury.
Hepatol Res
; 2024 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38642343
3.
Prediction of Therapeutic Response Using Contrast-Enhanced Ultrasound in Japanese Patients Treated with Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma.
Oncology
; 101(3): 173-184, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36516803
4.
Impact of Renal Function on the Prognosis of Patients Receiving Atezolizumab/Bevacizumab Combination Therapy and Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma.
Oncology
; 101(10): 609-623, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37279708
5.
Relationship between Plasma IP-10/CXCL10 Levels and the Initial Therapeutic Response in Patients Treated with Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
Oncology
; 101(10): 655-663, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37379802
6.
Significance of serum IP-10/CXCL10 measurement in predicting post-direct acting antiviral treatment liver function in patients with HCV-decompensated liver cirrhosis.
Hepatol Res
; 53(4): 280-288, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36445119
7.
Early diagnosis of hepatic inflammation in Japanese nonalcoholic fatty liver disease patients using 3D MR elastography.
Hepatol Res
; 53(3): 208-218, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36372908
8.
Effect of a combination of pemafibrate and a mild low-carbohydrate diet on obese and non-obese patients with metabolic-associated fatty liver disease.
J Gastroenterol Hepatol
; 38(6): 921-929, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36811251
9.
Plasma Renin Activity Predicts Prognosis and Liver Disease-Related Events in Liver Cirrhosis Patients with Ascites Treated by Tolvaptan.
Dig Dis
; 40(4): 479-488, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34348262
10.
Deep sequencing analysis of serum hepatitis B virus-RNA during nucleot(s)ide analogue therapy.
Hepatol Res
; 51(1): 39-50, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32961003
11.
Incidence and hemodynamic feature of risky esophageal varices with lower hepatic venous pressure gradient.
Int J Med Sci
; 16(12): 1614-1620, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31839749
12.
Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct-acting antivirals for hepatitis C virus.
Hepatol Res
; 48(13): 1131-1139, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30030872
13.
Up-to-seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child-Pugh grade deterioration after initial conventional transarterial chemoembolization.
Hepatol Res
; 48(6): 442-450, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29278654
14.
Assessment of lower limb muscle strength can predict fall risk in patients with chronic liver disease.
Sci Rep
; 14(1): 64, 2024 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38168920
15.
Usefulness of Body Position Change during Local Ablation Therapies for the High-Risk Location Hepatocellular Carcinoma.
Cancers (Basel)
; 16(5)2024 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38473393
16.
Spontaneous portosystemic shunt diameter predicts liver function after balloon-occluded retrograde transvenous obliteration.
JGH Open
; 6(2): 139-147, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35155824
17.
Analysis of direct-acting antiviral-resistant hepatitis C virus haplotype diversity by single-molecule and long-read sequencing.
Hepatol Commun
; 6(7): 1634-1651, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35357088
18.
Usefulness of Cell-Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment Efficacy.
Hepatol Commun
; 5(11): 1927-1938, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34558819
19.
Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures.
PLoS One
; 14(2): e0211122, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30768601
20.
Baseline and Early Predictors of Good Patient Candidates for Second-Line after Sorafenib Treatment in Unresectable Hepatocellular Carcinoma.
Cancers (Basel)
; 11(9)2019 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31461985